Offer extended until 31 July 2026: get a 10% early-bird discount on all events starting on or after 25 August 2026. To the promotion
GMP search engine – look up GMP compliance regulations and news
Pharmeuropa: Revised Chapter 2.9.1. "Disintegration of tablets and capsules" published for comment
Recommendation
Tuesday, 10 November 2026 9 .00 - 17.00 h
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
In the Pharmeuropa issue 35.2, a proposal for a revised chapter 2.9.1 "Disintegration of tablets and capsules" was published. The deadline for submitting comments is 30 June 2023.
The test of disintegration is provided to determine whether tablets or capsules disintegrate within the prescribed time when placed in a liquid medium under the experimental conditions presented in the chapter.
According to the briefing notes, compared to the monograph published in the 11th Edition of the Ph. Eur., the following changes are proposed:
- "Test B (intended for tablets and capsules larger than 18 mm) has been harmonised.
- A reference to ISO and ASTM standards has been added for the low-form beaker.
- An additional requirement for the inner diameter of the beaker used for Test B has been introduced.
- The general chapter also now explicitly allows the use of automatic disintegration detection instruments."
The full text and further details on the revision and can be found, after registration, on the Pharmeuropa website.
Related GMP News
02.11.2026FDA Warning Letter: When Test Procedures Allow Retesting Until an Acceptable Result is Obtained
21.10.2026EMA Updates Information Page on Bioequivalence Guidelines
21.10.2026BP Publishes new Draft Texts
21.10.2026FDA Identifies Critical Deficiencies in Analytical Testing and CGMP Oversight
07.10.2026Analytical Quality Group Developments May through August 2026
07.10.2026Two New FDA Warning Letters Put OOS Investigations in Focus